AK

Avinash Kumar

Active Director Director DIN 09456663
DIN 09456663 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Avinash Kumar

Data last updated:

Avinash Kumar is a Director at Amrit Healthcare And Research Center Private Limited (since 2022). The company operates in Healthcare.

DIN 09456663
Primary Designation Director
Industry Healthcare
First Appointment 04 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20222022Active

Directorship timeline

Open interactive timeline →
Amrit Healthcare And Research Center Private Limited
Premium access

Shareholding and investment profile for Avinash Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Kumar

Avinash Kumar currently holds 1 directorship: Amrit Healthcare And Research Center Private Limited (Director, since 04 Jan 2022).

Avinash Kumar was first appointed on 04 Jan 2022 as Director at Amrit Healthcare And Research Center Private Limited.

The current boards of Avinash Kumar's companies include Amit Kumar (Amrit Healthcare And Research Center Private Limited), Ashish Kumar (Amrit Healthcare And Research Center Private Limited), Bhaskar Kumar (Amrit Healthcare And Research Center Private Limited), Sutendra Pal Singh (Amrit Healthcare And Research Center Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available